However, a reduced B16 melanoma cell line metastatic burden was observed in KLRG1-deficient mice compared with wildtype controls [152], confirming the inhibitory function of KLRG1 in the anti-tumor immune response. This evidence concerns the gene KLRG1 and neoplasm.